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ABSTRACT
Objective: Bacterial vaginosis is associated with an unexplained loss of vaginal lactobacilli. Previ-
ously, we have identified certain vaginal lactobacilli-released phages that can inhibit in vitro other
vaginal lactobacilli. However, there is no apparent route for phages to be transmitted among
women. The purpose of this study was to identify whether certain Lactobacillus products commonly
used by women release phages or bacteriocins that can inhibit vaginal lactobacilli.
Methods: From 26 Lactobacillus products (2 acidophilus milks, 20 yogurts, 3 Lactobacillus pills,
and 1 vaginal douche mix), lactobacilli were isolated with Rogosa SL agar (Difco, Detroit, MI).
From these lactobacilli, phages and bacteriocins were induced with mitomycin C and tested against
a collection of vaginal Lactobacillus strains.
Results: From the 26 products, 43 Lactobacillus strains were isolated. Strains from 11 yogurts
released phages, among which 7 inhibited vaginal lactobacilli. Eleven strains released bacteriocins
that inhibited vaginal lactobacilli. While about one-half of the vaginal strains were lysed by bacte-
riocins, less than 20% were lysed by phages.
Conclusions: Some vaginal lactobacilli were inhibited in vitro by phages or bacteriocins released
from Lactobacillus products used by women, implying that vaginal lactobacilli may be reduced
naturally due to phages or bacteriocins from the environment. Infect. Dis. Obstet. Gynecol. 5:244-
251, 1997. (C) 1997 Wiley-Liss, Inc.
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hile lactobacilli can be quite common and
inconsequential environmental bacteria,
lactobacilli indigenous to the human vagina arc
beneficial to women’s health. These bacteria nor-
mally produce lactic acid that maintains a pH of
4.0-4.5 and thus prevents vaginal infections caused
by other microorganisms. However, an unex-
plained decrease of vaginal lactobacilli occurs dur-
ing bacterial vaginosis (BV). e Women who suffer
from BV may have an increased, milk-like dis-
charge that has an unpleasant odor3 and an in-
creased risk to develop pelvic infections or prema-
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ture labor during pregnancy.
4 Although BV is a
common vaginal infection, its cause is unknown.
Women who are sexually active appear to be at a
higher risk for BV, but BV has not been confirmed
to be a sexually transmitted disease because it also
occurs among women who are not sexually active.3
Recently, BV has been defined as a condition in
which the normal Lactobacillus-predominant flora is
replaced with anaerobic bacteria, Gardnerella vagi-
nalis, and J/lycoplasma hominis.4 Because the anaero-
bic bacteria are sensitive to hydrogen peroxide and
lactic acid produced by vaginal lactobacilli, anaer-
obes theoretically should not outnumber lactoba-
cilli,s-7 Therefore, during the initiation of BV, vagi-
nal lactobacilli might decrease first, thus allowing
anaerobes to overgrow.
Several possible mechanisms by which vaginal
lactobacilli decrease have been proposed. These
include douching,
8 the use of spermicide, such as
Nonoxynol 9,
9 and treatment with antibiotics for
other infections. It is unknown, however, whether
vaginal lactobacilli could decrease by natural
causes. Previously, we have reported that some
vaginal lactobacilli are lysogens that release phages,
the viruses that infect bacteria.1 These phages
could infect many vaginal lactobacilli in vitro. This
observation suggested that vaginal lactobacilli can
be inhibited naturally by phages released from
other vaginal lactobacilli. However, there is no ap-
parent route for infective phages to be transmitted
among women. Therefore, if phages are involved
in the natural reduction of vaginal lactobacilli,
which might occur frequently because BV is com-
mon, alternative sources of phages that are exposed
to women may exist. One such source could be the
environment, such as Lactobacillus-containing
foods, vaginal douches, or suppository tablets.
Various products containing lactobacilli, such as
yogurt, acidophilus milk, vaginal suppository tab-
lets or capsules, and vaginal douche mix, have been
used by women to treat vaginal infections,s,l Al-
though the method of delivery varies--ingestion,
vaginal instillation, or douchingmthe effects of the
products have been inconsistent, le To test the hy-
pothesis that phages or bacteriocins, which are an-
tibacterial agents produced by bacteria, from the
environment may inhibit vaginal lactobacilli, we
analyzed whether some Lactobacillus products,
through the release of phages or bacteriocins, could
inhibit endogenous vaginal lactobacilli in vitro.
MATERIALS AND METHODS
Twenty-six Lactobad//us products were purchased
at local pharmacies, grocery stores, and health-food
establishments. These products included 2 acido-
philus milks, 20 yogurts, 3 Lactobacillus pills, and
Lactobacillus vaginal douche mix. The brand names
and manufacturers of these products are listed in
Table 1.
To isolate Lactobacillus strains from these prod-
ucts, a loop full of each product was streaked on the
Rogosa SL agar (Difco, Detroit, MI) and incubated
in a candle jar at 37C for 48 h. Each Lactobacillus
isolate was identified on the basis of growth on
Rogosa SL agar, gram-positive staining, rod cell
morphology, and catalase-negative reaction. Lacto-
bacillus species were tentatively identified accord-
ing to their sugar fermentation patterns compared
with the scheme described in Bergey’s Manual
and by an assay based on polymerase chain reaction
(PCR) developed in our laboratory (unpublished
data). From these Lactobacillus isolates, both bacte-
riophages and bacteriocins were induced by the
mitomycin C method.4 Briefly, 0.1 ml of overnight
Lactobacillus culture in MRS broth (pH 5.5; Difco)
was transferred into 10 ml prewarmed fresh MRS
broth. After 3 h of incubation, the culture was di-
vided equally into two test tubes. One tube was
used as control, and the other had mitomycin C
(Sigma, St. Louis, MO) added at a final concentra-
tion of 0.2 pg/ml. The induction of Lactobacillus
phages or bacteriocins was indicated by a rapid re-
duction of optical density of the culture 5-7 h after
the addition of mitomycin C. The lysates were cen-
trifuged and filtered to remove unlysed cells and
maintained at 4C. Each lysate was tested for its
inhibitory effect against a collection of 37 human
vaginal Lactobadllus strains, which were isolated
from 27 women (1 Native American, 5 Blacks, 5
Asians, and 16 Caucasians).
Bacteriophages were differentiated from bacte-
riocins by the following procedures: 1) phage
plaque assay; 2) isolation of phage DNA with the
Qiagen kit (Qiagen, Chatsworth, CA); 3) hybridiza-
tion of Lactobacillus chromosomal DNA with a non-
radioactive biotin-labeled Lactobacillus phage DNA
probe (Life Technologies, Gaithersburg, MD); and
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TABLE I. Lactobacillus products analyzed in this study
Product Manufacturer Location
Acidophilus milk
Anderson Erickson Anderson Erickson Dairy Co. Des Moines, IA 19053
Fairmont-Zarda Fairmont-Zarda Div. Roberts Dairy Co. Omaha, NE 68101
Yogurt
Alta Dena Alta Dena Certified Dairy, Inc. Noustry, CA 91744
Always Save Associated Wholesale Grocers, Inc. Kansas City, KS 66106
Anderson Erickson Anderson Erickson Dairy Co. Des Moines, IA 19053
Belfonte Belfonte Ice Cream Co. Kansas City, MO 64127
Best Choice Lite Associated Wholesale Grocers, Inc. Kansas City, KS 66106
Breyers Kraft General Foods, Inc. Glenview, IL 60025
Cascadefresh Cascadefresh, Inc. Seattle, WA 98125
Colombo Colombo, Inc. Minneapolis, MN 55440
Dannon Dannon Jacksonville, FL 32231
Dillons Dillon’s Store Div. of Dillon Co., Inc. Hutchinson, KS 67501
Fairmont-Zarda Fairmont-Zarda Dairy Co. Kansas City, MO 64128
Great Value Wal*Mart Stores, Inc. Bentonville, AR 72716
Horizon Organic Natural Horizon, Inc. Boulder, CO 80301
Mountain High Mountain High, Inc. Englewood, CO 80110
Schnucks Lite Schnuck Market, Inc. St. Louis, MO 63106
TCBY Polytainers, Inc. Little Rock, AR 72201
Weight Watcher Weight Watcher International, Inc. Pittsburgh, PA 15230
Wells’ Blue Bunny Wells’ Dairy, Inc. LeMars, IA 51031
Yonson Favorite Foods, Inc. Fullerton, CA 92631
Yoplait Yoplait USA, Inc. Minneapolis, MN 51031
Lactobacillus pill
Lactinex Becton-Dickinson Microbiology Sys. Cockeysville, MD 21030
Nature’s Plus Natural Organics, Inc. Melville, NY II 747
Solaray Solaray, Inc. Ogden, UT 84403
Lactobacillus douche
Hygenia Schiff Products, Inc. Moonachie, NJ 07074
aThe strains isolated from the 2 acidophilus milks were designated A and A2. The strains isolated from the 20 yogurts were designated Y I-Y20. The
strains isolated from the Lactobacillus pills and vaginal douche mix were designated L I-L4. To protect the reputation of these commercial products,
the sources of the phages and bacteriocins are not specifically indicated.
4) observation of the phages under an electron mi-
croscope. 1- Additionally, phage DNA fingerprint-
ing analysis with restriction enzyme digestion and
subsequent electrophoresis
6 was used to identify
whether the isolated phages were genetically re-
lated. If no phages were identified from a mitomy-
cin C-induced lysate, its inhibitory effect was ana-
lyzed for Lactobaci/lus bacteriocins. Catalase was
added and pH was neutralized to rule out the ef-
fects of hydrogen peroxide and acid, respectively.
The lysate was also heated at 100C for 10 rain and
treated with proteolytic enzymes (trypsin, pepsin,
and protease) to characterize the bacteriocins.
The assay for phage infection or bactcriocin in-
hibition was performed as described previously. 15
Briefly, an aliquot of Lactobacillus indicator culture
at mid-exponential growth phase was mixed with
soft agar (48C) made of the Lactobacills MRS me-
dium supplemented with 10 mM CaC1z (MRS-C)
and poured onto an MRS-C agar plate. The in-
duced lysates were dropped onto the solidified soft
agar, and the plates were incubated for 24 h at
37C. The phage infection or bacteriocin lysis was
indicated by a clear lysis zone in the soft agar layer.
To extend the range of Lactobacillus species and
strains beyond those isolated from the 27 patients
and the 26 Lactobacillus products, an additional 11
Lactobacillus strains were also tested. These in-
cluded 7 strains from American Type Culture Col-
lection (ATCC; Rockville, MD), 3 strains from Na-
tional Collection of Dairy Organisms (NCDO;
Reading, England), and strain from Dr. Klaen-
hammer (North Carolina State University, Ra-
leigh). The 3 human strains (1 intestinal strain, L.
gasseri ADH; and 2 vaginal strains, L. gasseri ATCC
9857 and L. jensenii ATCC 25258) were used as
additional indicator strains, while the 8 dairy strains
(L. delbruecbii subsp, bulgaricusNCDO 1489, ATCC
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TABLE 2. Inhibition of exogenous Lactobacillus strains on vaginal lactobacilli by releasing phages or bacteriocins
in vitro
No. of total Indicator strain
b
Exogenous sensitive strains La Lg Lc Lj Lp Lf Ldl
effector strain (N/4 I) (3) (I 0) (I 8) (5) (I) (3) (I)
Phage releaser
YI5 7 2 2 0 0
Y8 5 2 0 0 0
YI6 3 0 0 0 0
YI, YI0, YII 2 0 0 0 0 0
YI9 2 0 0 0 0 0
Y2, Y5, YI2a, YI3 0 0 0 0 0 0
Bacteriocin producer
NCDO 1489 19 0 15 2 0 0
LI II 3 4 0
NCDO 2395 10 2 4 0
YI2b 10 2 2 0 5 0 0
L2 7 0 0 5 0 0
Y3 6 0 3 0 0
YI7 3 0 0 3 0 0 0 0
YI4 2 0 2 0 0 0 0 0
YI8 2 0 0 0 0 0
AI, A2, Y6 0 0 0 0 0 0
Y7, Y9, Y20, L4 0 0 0 0 0 0
aStrains that gave the same results are listed in the same line.
bVaginal Lactobacillus species: La, L. acidophilus; Lg, L. gasseri; Lc, L. crispatus: Lj, L. jensenii; Lp, L. plantarum; Lf, L. fermentum; Ldl, L. delbrueckii subsp, lactis
ATCC 15808. The total number of strains of each species is indicated in parentheses.
11842, ATCC 27558, and ATCC 9649; L. de/brueckii
subsp, lactis ATCC 15808; L. helveticus NCDO 87,
NCDO 2395, and ATCC 15009) were used as ad-
ditional effector strains.
Electron microscopy was performed as de-
scribed previously.1 Briefly, one drop of the puri-
fied phage by8 in 0.1 M ammonium acetate (pH
7.0) was spotted on grids with a carbon-coated For-
mvar film (Ladd Research Industries, Inc., Burling-
ton, VT). After drying for 30 sec, the sample was
negatively stained with 2% uranyl acetate (pH 4.2)
and observed under a CM12 Philips transmission
electron microscope (Philips Electronic Instru-
ments, Inc., Mahwah, NJ) at 80 kV.
RESULTS
Among 26 products, 43 Lactobaci//us strains were
isolated with some products containing multiple
Lactobadllus strains. According to their sugar fer-
mentation patterns,
13 sensitivity patterns to a col-
lection of dairy Lactobadllus phages and bacterio-
cins, plasmid profiles and phage contents, and the
PCR assay based on their 16S RNA gene sequence
(data not shown), the isolates were tentatively
identified as the following species: L. acidophilus
(23 strains divided into 2 groups: A, 10 strains with
a 6 kb cryptic plasmid; and B, 13 strains without a
plasmid), L. helveticus (2 strains), L. delbrueckii
subsp, bulgaricus (13 strains), L. delbrueckii subsp.
lactis (2 strains), and L. plantarum (3 strains). On the
other hand, the human vaginal Lactobacillus species
used as indicator strains included: L. acidopailus (3
strains), L. crispatus (18 strains), L. fermentum (3
strains), L. gasseri (9 strains), L. jensenii (5 strains),
and L. plantarum (1 strain). Also included as indi-
cators were a human intestinal strain L. gasseri
ADH and a dairy strain L. ddbrueckii subsp, lactis
ATCC 15808. The latter has been commonly used
as a phage indicator strain in Lactobacillus phage
studies because it is susceptible to a broad range of
Lactobacillus species and could show clear phage
plaques.1
In the phage infection and bacteriocin lysis ex-
periment, a collection of 50 induced lysates (43
from the 26 Lactobacillus products and 7 from the
dairy type strains) was used to cross-interact with
the 41 (39 vaginal, intestinal, and dairy) indi-
cator strains. The results are shown in Table 2.
While about one-half of the human vaginal strains
displayed bacteriocin-induced lysis, less than 20%
were sensitive to the dairy phages. By phage
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Fig. I. Lactobacillus phage and bacteriocin assay. The indi-
cator strain was L. delbrueckii subsp, lactis ATCC 15808.
Positive inhibitions were shown by lysates from the follow-
ing strains: (/) NCDO 2395, (B) L2, (12) Lib, (D) L la, (i)
A I, (F) A2, (G) Y8, (H) Y I, (I) Y I, (I) Y2, (K) Y 3, (L)
plaque assay and by DNA hybridization with the
phage by8 DNA isolated from a particular brand of
yogurt, 11 yogurt strains were identified to release
phages. However, only 7 of these yogurt phages
lysed the human vaginal Lactobacillus strains tested.
The rest of the inhibitions were presumably caused
by bacteriocins. The bacteriocins from a Lactobacil-
lus tablet (L1) and from a yogurt (Y12b) were very
potent: both lysed multiple vaginal Lactobadllus
strains. Bacteriocins isolated from A1, A2, and Y12b
were heat stable as they were active against other
lactobacilli even after boiling for 10 min. The bac-
teriocin inhibition pattern of L1 was remarkably
similar to that of the type strain of L. hdveticus
NCDO 2395.
Most of the phages were readily identified by
direct plaque assay with the indicator strain L. del-
brueckii subsp, lactis ATCC 15808. When a lysis
zone displayed multiple small clear plaques within
or even adjacent to a turbid lysis zone (Fig. 1), the
small plaques were caused by phages. The turbid
zone was apparently caused by an antimicrobial ac-
tivity. The zone disappeared after a 10-fold dilu-
tion of the lysate, but the small clear plaques re-
mained. The DNA fingerprinting analysis (data not
shown) indicated that 10 phages (qbyl, dy2, qbyS,
by8, qbyl0, byll, dyl2a, byl3, byl6, and qbyl9)
Y5, (11) Y I0a, (hi) Y I0b, and (O) Y 6. The remaining 23
sample lysates did not lyse ATCC 15808. Each of the small
clear plaques in or near a lysis zone is caused by infection of
a single bacteriophage. The phage infection or bacteriocin
lysis was indicated by a clear lysis zone in the soft agar layer.
belonged to the same genetic type, although some
of these phages had slightly different host ranges
(Table 2). We have extensively studied the phage
by8, released from L. acidophilus Y8, the starter
strain of a particular brand of yogurt, which was
used to treat vaginal yeast infection. 11 The plaque
morphology of y8 is shown in Figure 1G, and its
phage ultrastructural morphology is shown in Fig-
ure 2. L. addophilus Y8 cells burst due to sponta-
neous phage induction at a rate of approximately
10-’ with a burst size of about 100 phages/cell. The
phage y8 had a linear double-stranded DNA of
about 54 kb. It lysed 4 vaginal Lactobacillus strains
and dairy strain tested. More detailed data about
the phage by8 are reported in a separate paper,
is
DISCUSSION
Phages and bacteriocins have been well studied in
dairy lactobacilli because lactobacilli are important
starter cultures for processing dairy foods, espe-
cially yogurt.
5 Phages also have been isolated from
sewage, sausages, or meat cultures and the human
intestine and vagina. s,17-19 Unlike phages, bacte-
riocins are non-viable molecules of proteins or pep-
tides. Many lactobacilli have been found to pro-
duce bacteriocins of various types,e Usually, bac-
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Fig. 2. Electron micrograph of Lactobacillus phage by8 from a yogurt.
tcriocins made of small pcptidcs can resist heat
and/or protcascs, while bacteriocins made of large
protein molecules can bc sensitive to both. The
fact that certain commercial Lactobaci/lus products
also released phages or bactcriocins was not sur-
prising. It was of interest, however, that some of
these phages and bactcriocins lyscd human vaginal
lactobacilli under in vitro conditions (Table 2).
This observation implied that vaginal lactobacilli
could be inhibited by Lactobaci//us phages or bac-
teriocins from environmental sources.
Unlike antibiotics, which can inhibit a broad
spectrum of bacteria, bactcriocins normally only in-
hibit the same type of bacteria as their producers.
Therefore, bacteriocins produced by a Lactobaci//us
strain would most likely inhibit other lactobacilli,e
While both phages and bacteriocins can inhibit
vaginal lactobacilli under in vitro conditions, Lac-
tobacillus phages appear to have a relatively nar-
rower host range than bacteriocins. However, a
lytic phage may cause greater damage. Once a sen-
sitive Lactobacillus strain encounters a virulent
phage, the phage can be rapidly reproduced in the
bacterial host cells, releasing millions of new
phages that can soon eliminate the entire sensitive
strain. Conversely, a bacteriocin-producing Lacto-
bacillus strain may only cause a limited or a slow
adverse effect on a preexistent sensitive strain be-
cause bacteriocins cannot be reproduced by target
cells and can only kill target cells upon direct con-
tact. Therefore, phage-releasing lysogens can be
more virulent than bacteriocin producers in attack-
ing other Lactobacillus strains.
We have recently identified that some vaginal
lactobacilli release phages, which can efficiently in-
fect the same or other vaginal lactobacilli.1 Be-
cause there is no apparent route for infective vagi-
nal Lactobacillus phages to be transmitted among
women, it was hypothesized that phages that can
infect vaginal lactobacilli may have other sources,
such as the environment. Because BV is a common
vaginal infection, natural reduction or elimination
of vaginal lactobacilli must frequently occur in
women,e-4 However, results from the current study
showed that the efficiency of phage infection was
not very high--less than 20% of vaginal Lactobacil-
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]us strains tested were sensitive to phages released
from dairy lactobacilli. The data suggested that al-
though vaginal lactobacilli can be infected by dairy
phages, vaginal lactobacilli might not be a pre-
ferred host for these phages, probably due to host-
range limitations. Moreover, each day millions of
people ingest lactobacilli in various yogurt prod-
ucts, but no apparent side effects have been re-
ported. Therefore, if phages can indeed affect the
population of vaginal lactobacilli in vivo in humans,
additional environmental phage sources may exist.
A recent study by Antonio and Hillierel showed
that in many women the vaginal Lactobacillus spe-
cies are identical to their intestinal or rectal Lacto-
bacillus species. This observation, together with our
earlier observation that a phage released from an
intestinal Lactobacillus strain lysed multiple vaginal
Lactobacillus isolates,1 suggested that intestinal
lactobacilli might be a reservoir for phages that in-
fect vaginal lactobacilli. Because the intestine is an
open ecological system, intestinal lactobacilli can
be originated from various environmental sources,
such as food products. Therefore, foods containing
lactobacilli that can colonize the intestine and
eventually become a part of intestinal microflora
may be critical if these lactobacilli release phages
that can efficiently infect vaginal lactobacilli.
In summary, phages and bacteriocins released
from some Lactobacillus products including yogurt,
acidophilus milk, tablets, and douche mix inhibited
some human vaginal Lactobacillus isolates under in
vitro conditions. Whereas bacteriocins were iso-
lated from all groups of products studied, phages
were isolated only from yogurts. The natural inhi-
bition of vaginal lactobacilli by phages or bacterio-
cins may be important for studying the initiation of
BV because BV is associated with an unexplained
decrease of vaginal lactobacilli. Although similar in-
hibitions observed in vitro may not necessarily oc-
cur in vivo in humans, these observations, however,
implied a possibility that vaginal lactobacilli might
be inhibited naturally by phages or bacteriocins re-
leased by lactobacilli from the environment. Fur-
ther studies will be required to identify additional
phage sources and to detect infective phages in
vivo in the human vagina.
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